Biotechnology
Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. The company is a trailblazer in anti-FcRn technology, developing innovative, targeted therapies to meet the complex and variable needs of patients with autoimmune diseases. Immunovant is advancing multiple development programs through clinical trials, with a focus on delivering scientifically rigorous treatments that address unmet medical needs in the autoimmune disease space.
Industry
Biotechnology
Remote Policy
Fully Remote
Beta · Sourced from candidate reports
Be the first to share your experience with Immunovant, Inc..
Your reply helps other candidates know what to expect.
